A federal district court has denied a pharmaceutical manufacturer’s motion to dismiss a suit brought by the Department of Justice (DOJ) alleging that the company violated the Anti-Kickback Statute and the False Claims Act by funneling millions of dollars to a purportedly independent foundation that subsidized patients’ co-pays in order to induce physicians to prescribe one of ... Read More